Explore Pfizer’s evolving pipeline strategy, expanding into oncology and obesity to drive growth beyond its COVID-19 success.
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in ...
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has granted full approval to BRAFTOVI® (encorafenib) in combination ...
EU MADE SIMPLE on MSN
How 'Pfizergate' could come back to haunt Brussels
The “guilty” framing is headline-worthy, but the core issue is accountability and transparency, not a criminal verdict. An EU ...
Report by Irish Fiscal Advisory Council highlights ‘exceptionally concentrated’ nature of Ireland’s corporate tax base ...
Tempo verified the information by examining the Epstein Files, comparing them with credible sources, and interviewing public ...
President Donald Trump has found himself in an odd juxtaposition as traditional allies are pushing back on his Most Favored Nation (MFN) plan to reduce the price of prescription drugs. < | As ...
Joseph Edlow, the director of U.S. Citizenship and Immigration Services, also testified and underscored the administration’s ...
FLORENCE, CA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Helping Professionals Land Interviews and Offers ...
Blinded evaluation of safety and tolerability data by the Safety Monitoring Committee from Cohort 1 and advancement to Cohort 2 is expected in 3Q 2026 - - Advancement reflects continued execution of ...
- Advancement reflects continued execution of capital-efficient development strategy leveraging POZ Platform™ - ...
Citi's 2026 Virtual Oncology Leadership Summit February 18, 2026 2:30 PM ESTCompany ParticipantsJacob Chacko - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results